Skip to main content

JHOP - June 2026 Vol 16, No 3

Original Research
Symptom Management Overview
Original Research
Online First
Original Research, Checkpoint Inhibitors, Adverse Events, Lung Cancer
Impact of Hyperglycemia During Immune Checkpoint Inhibitor Treatment for Advanced Non–Small Cell Lung Cancer: A Retrospective, Single-Center Study
Allison L. Thurman, PharmD; Susan Storey, PhD, RN, ACONS, FCNS; David J. Reeves, PharmD, BCOP
Read More
Online First
Original Research, Adverse Events, Drug–Drug Interaction
Management Patterns and Perceived Educational Needs Related to Cancer Therapy Cardiovascular Toxicities for Cardio-Oncology Providers
Sarah Kaspari, PharmD; Heather Moore, PharmD, BCOP, CPP; Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS, CACP; Sarah Hayes, PharmD, BCOP; Kristen Santiago, PharmD, BCOP; Israa Yaseen, BPharm, BCCP, BCPS, FACC, et al.
Read More
Online First
Original Research, Checkpoint Inhibitors, Infusion Issues, PD-1 Inhibitors
Infusion-Related Reactions Associated With Nivolumab and Pembrolizumab: A Case Series Analysis
Jessica H. Tran, PharmD; Kelly M. Brunk, PharmD, BCOP; Grace A. Martin, PharmD, BCOP
Read More
Symptom Management Overview
Online First
Symptom Management Overview, Breast Cancer, Targeted Therapies
HER2 Heartbreak? Understanding the Management of Cardiotoxicity From Trastuzumab in HER2-Positive Breast Cancer
Courtney Muche, PharmD; Matthew Mattila, PharmD, BCOP
Read More